151 related articles for article (PubMed ID: 24845232)
1. Clinicopathological significance of ASC amino acid transporter-2 expression in pancreatic ductal carcinoma.
Kaira K; Sunose Y; Arakawa K; Sunaga N; Shimizu K; Tominaga H; Oriuchi N; Nagamori S; Kanai Y; Oyama T; Takeyoshi I
Histopathology; 2015 Jan; 66(2):234-43. PubMed ID: 24845232
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer.
Toyoda M; Kaira K; Ohshima Y; Ishioka NS; Shino M; Sakakura K; Takayasu Y; Takahashi K; Tominaga H; Oriuchi N; Nagamori S; Kanai Y; Oyama T; Chikamatsu K
Br J Cancer; 2014 May; 110(10):2506-13. PubMed ID: 24762957
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of LAT1 and ASCT2 in patients with surgically resected esophageal squamous cell carcinoma.
Honjo H; Kaira K; Miyazaki T; Yokobori T; Kanai Y; Nagamori S; Oyama T; Asao T; Kuwano H
J Surg Oncol; 2016 Mar; 113(4):381-9. PubMed ID: 26936531
[TBL] [Abstract][Full Text] [Related]
4. ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer.
Shimizu K; Kaira K; Tomizawa Y; Sunaga N; Kawashima O; Oriuchi N; Tominaga H; Nagamori S; Kanai Y; Yamada M; Oyama T; Takeyoshi I
Br J Cancer; 2014 Apr; 110(8):2030-9. PubMed ID: 24603303
[TBL] [Abstract][Full Text] [Related]
5. Clinical associations between ASCT2 and p‑mTOR in the pathogenesis and prognosis of epithelial ovarian cancer.
Guo H; Xu Y; Wang F; Shen Z; Tuo X; Qian H; Wang H; Wang K
Oncol Rep; 2018 Dec; 40(6):3725-3733. PubMed ID: 30272366
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the neutral amino acid transporter ASCT2 in human colorectal adenocarcinoma.
Witte D; Ali N; Carlson N; Younes M
Anticancer Res; 2002; 22(5):2555-7. PubMed ID: 12529963
[TBL] [Abstract][Full Text] [Related]
7. GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma.
Sun HW; Yu XJ; Wu WC; Chen J; Shi M; Zheng L; Xu J
PLoS One; 2016; 11(12):e0168907. PubMed ID: 28036362
[TBL] [Abstract][Full Text] [Related]
8. Expression of Amino Acid Transporters (LAT1 and ASCT2) in Patients with Stage III/IV Laryngeal Squamous Cell Carcinoma.
Nikkuni O; Kaira K; Toyoda M; Shino M; Sakakura K; Takahashi K; Tominaga H; Oriuchi N; Suzuki M; Iijima M; Asao T; Nishiyama M; Nagamori S; Kanai Y; Oyama T; Chikamatsu K
Pathol Oncol Res; 2015 Sep; 21(4):1175-81. PubMed ID: 26024742
[TBL] [Abstract][Full Text] [Related]
9. High c-Met expression in stage I-II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correlation with poor prognosis.
Neuzillet C; Couvelard A; Tijeras-Raballand A; de Mestier L; de Gramont A; Bédossa P; Paradis V; Sauvanet A; Bachet JB; Ruszniewski P; Raymond E; Hammel P; Cros J
Histopathology; 2015 Nov; 67(5):664-76. PubMed ID: 25809563
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer.
Kaira K; Sunose Y; Arakawa K; Ogawa T; Sunaga N; Shimizu K; Tominaga H; Oriuchi N; Itoh H; Nagamori S; Kanai Y; Segawa A; Furuya M; Mori M; Oyama T; Takeyoshi I
Br J Cancer; 2012 Aug; 107(4):632-8. PubMed ID: 22805328
[TBL] [Abstract][Full Text] [Related]
11. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival.
Ye HL; Li DD; Lin Q; Zhou Y; Zhou QB; Zeng B; Fu ZQ; Gao WC; Liu YM; Chen RW; Li ZH; Chen RF
World J Gastroenterol; 2015 Jun; 21(21):6621-30. PubMed ID: 26074700
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of coexpression of L-type amino acid transporter 1 (LAT1) and ASC amino acid transporter 2 (ASCT2) in lung adenocarcinoma.
Yazawa T; Shimizu K; Kaira K; Nagashima T; Ohtaki Y; Atsumi J; Obayashi K; Nagamori S; Kanai Y; Oyama T; Takeyoshi I
Am J Transl Res; 2015; 7(6):1126-39. PubMed ID: 26279756
[TBL] [Abstract][Full Text] [Related]
13. Clinical implication of Sox9 and activated Akt expression in pancreatic ductal adenocarcinoma.
Xia S; Feng Z; Qi X; Yin Y; Jin J; Wu Y; Wu H; Feng Y; Tao M
Med Oncol; 2015 Jan; 32(1):358. PubMed ID: 25428381
[TBL] [Abstract][Full Text] [Related]
14. High toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer patients.
Leppänen J; Helminen O; Huhta H; Kauppila JH; Isohookana J; Haapasaari KM; Lehenkari P; Saarnio J; Karttunen TJ
Virchows Arch; 2017 Apr; 470(4):401-410. PubMed ID: 28191612
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic features and prognostic implications of MYBL2 protein expression in pancreatic ductal adenocarcinoma.
Yu R; Li C; Lin X; Chen Q; Li J; Song L; Lin L; Liu J; Zhang Y; Kong W; Ouyang X; Chen X
Pathol Res Pract; 2017 Aug; 213(8):964-968. PubMed ID: 28559119
[TBL] [Abstract][Full Text] [Related]
16. Microvessel Landscape Assessment in Pancreatic Ductal Adenocarcinoma: Unclear Value of Targeting Endoglin (CD105) as Prognostic Factor of Clinical Outcome.
Lytras D; Leontara V; Kefala M; Foukas PG; Giannakou N; Pouliakis A; Dervenis C; Panayiotides IG; Karakitsos P
Pancreas; 2015 Jan; 44(1):87-92. PubMed ID: 25058886
[TBL] [Abstract][Full Text] [Related]
17. Mucin expression in endoscopic ultrasound-guided fine-needle aspiration specimens is a useful prognostic factor in pancreatic ductal adenocarcinoma.
Higashi M; Yokoyama S; Yamamoto T; Goto Y; Kitazono I; Hiraki T; Taguchi H; Hashimoto S; Fukukura Y; Koriyama C; Mataki Y; Maemura K; Shinchi H; Jain M; Batra SK; Yonezawa S
Pancreas; 2015 Jul; 44(5):728-34. PubMed ID: 25906442
[TBL] [Abstract][Full Text] [Related]
18. Tumor budding is an independent adverse prognostic factor in pancreatic ductal adenocarcinoma.
O'Connor K; Li-Chang HH; Kalloger SE; Peixoto RD; Webber DL; Owen DA; Driman DK; Kirsch R; Serra S; Scudamore CH; Renouf DJ; Schaeffer DF
Am J Surg Pathol; 2015 Apr; 39(4):472-8. PubMed ID: 25634751
[TBL] [Abstract][Full Text] [Related]
19. Expression of neutral amino acid transporter ASCT2 in human prostate.
Li R; Younes M; Frolov A; Wheeler TM; Scardino P; Ohori M; Ayala G
Anticancer Res; 2003; 23(4):3413-8. PubMed ID: 12926082
[TBL] [Abstract][Full Text] [Related]
20. Relationship between CD147 and expression of amino acid transporters (LAT1 and ASCT2) in patients with pancreatic cancer.
Kaira K; Arakawa K; Shimizu K; Oriuchi N; Nagamori S; Kanai Y; Oyama T; Takeyoshi I
Am J Transl Res; 2015; 7(2):356-63. PubMed ID: 25901202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
